GM/CEO, Clinical Trial Abundance Initiative

General Manager/CEO, Clinical Trial Abundance Initiative

Location: Remote (US-Based) | Type: Full-Time | Reports to: CEO, Philanthropic Foundation

EQL Tech is partnering with two philanthropic foundations collaborating to reshape the clinical trial landscape to ensure that groundbreaking therapies reach patients swiftly and equitably. The foundation aims to overcome systemic barriers that limit trial access and diversity, with a goal to improve the representativeness of clinical trial populations and maximize the impact of innovative solutions in health.

The foundation is seeking a General Manager/CEO for its nascent Clinical Trial Abundance Initiative. In this role, you will lead a transformative effort to decentralize clinical trial access, promoting a model that prioritizes patient-centered care and ensures diverse participation. You will develop and execute strategies that empower health systems, community organizations, and patients to engage more fully in the clinical trial process.

Key Responsibilities:

• Design and implement strategies to increase clinical trial accessibility, particularly for underrepresented populations.
• Collaborate with health systems, patient advocacy groups, and research institutions to streamline participation pathways and share effective outreach practices.
• Facilitate the integration of community engagement and ecosystem building methodologies into clinical trial planning and execution, ensuring trials reflect real-world patient diversity.
• Advocate for policy changes at local, state, and federal levels to enhance regulatory flexibility in clinical trial designs.
• Monitor and evaluate initiative progress, iterating on strategies based on data-driven insights and stakeholder feedback.
• Engage with thought leaders and subject matter experts to champion innovative practices that redefine the clinical trial framework.